AmacaThera doses First In Human Study to Evaluate, AMT-143, for Non-opioid Treatment of Postoperative Pain ...Middle East

PR Newswire - News
AmacaThera doses First In Human Study to Evaluate, AMT-143, for Non-opioid Treatment of Postoperative Pain
TORONTO, 15 mai 2024 /PRNewswire/ -- AmacaThera Inc, une société de biotechnologie en phase clinique spécialisée dans le développement de formulations avancées d'hydrogel à libération prolongée, a administré à son premier sujet humain le AMT-143, le principal actif de la société dans la...

Hence then, the article about amacathera doses first in human study to evaluate amt 143 for non opioid treatment of postoperative pain was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AmacaThera doses First In Human Study to Evaluate, AMT-143, for Non-opioid Treatment of Postoperative Pain )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News